Skip to main content
Clinical Trials/CTRI/2023/10/059151
CTRI/2023/10/059151
Not yet recruiting
Phase 4

Effect of Individualized Homoeopathic medicines in treatment of abnormal vaginal discharge among women of reproductive age group - NI

Central Council for Research in Homoeopathy0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: N768- Other specified inflammation of vagina and vulva
Sponsor
Central Council for Research in Homoeopathy
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Central Council for Research in Homoeopathy

Eligibility Criteria

Inclusion Criteria

  • 1\. Married women/ Unmarried sexually active
  • Women of age group 18\-45 years presenting with complaint of abnormal vaginal discharge.
  • 2\. Women who are already taking allopathic/alternative medicines will be enrolled after 7 days washout period.

Exclusion Criteria

  • 1\. Women with post coital bleeding or any vaginal/ cervical mass which bleeds on touch or any other sign/ symptom suspected of malignancy will be referred for standard care.
  • 2\. If any Sexually Transmitted Disease (for eg. Gonorrhea or Chlamydia) is found on culture, the patient will be excluded and advised to take Standard allopathic treatment along with partner
  • 3\. Pregnant and lactating women
  • 4\. Women with physiological leucorrhea
  • 5\. Women with uncontrolled or life threatening systemic illnesses
  • 6\. Unwilling to participate in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials